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Abstract
In the first part of this decade, many reviews of the impact of treatments for the eating disorders
were conducted, with broadly similar conclusions. This review provides an update on progress (or
otherwise) in the field over the past three years.
Introduction and context
The eating disorders have proven a challenge for
clinicians since they were first identified. Such patients
often have physical safety needs as a priority, and then
require effective therapy for the eating disorder itself.
This review focuses on recent developments in the latter
part of that process – treatment for the eating pathology.
Many authoritative treatment reviews have been pub-
lished in recent years [1-7], based on synthesis of both
the empirical evidence and expert clinical experience.
They include recommendations for both physical safety
and therapies, and have been relatively consistent in their
conclusions. Their key empirical findings regarding
therapies for the eating disorders are as follows.
For adult sufferers
1. Psychological treatments have relatively low levels of
impact on anorexia nervosa, and there is no clear
difference in outcome between such treatments.
2. Physical treatments for anorexia nervosa (for example,
nutrition or medication) are needed to ensure safety (for
example, biological safety or psychiatric risk), but there is
no consistent evidence that those treatments have an
impact on the anorexia nervosa itself.
3. Psychological treatments for bulimia nervosa and
binge eating disorder are relatively effective, with strong
evidence for the impact of cognitive behavioural therapy
(CBT) and interpersonal psychotherapy (the former
being faster to take effect than the latter).
4. Antidepressants (particularly fluoxetine) are effective
in reducing the level of bulimic symptoms in bulimia
nervosa and binge eating disorder, though the duration
of the effect may be short-term.
5. Self-help approaches have a relatively low level of
impact on the eating disorders, producing little impact
on abstinence from behaviours [8].
6. Apart from binge eating disorder, there is little evidence
of the impact of treatment for atypical cases (which
probably represent the largest number of sufferers [5]).
For younger sufferers
1. There is no clear evidence regarding what works for
children.
2. Adolescents with anorexia nervosa benefit more from
family-orientated therapies than individual therapies,
though there is little evidence for such a difference in
bulimic or atypical cases.
Of course, these conclusions should be read alongside
the expert clinical opinions that the guidelines use to
supplement the evidence base (particularly where there
is no real empirical base to rely on).
Recent advances
The past 3 years have yielded significant advances in our
knowledge base that are not reflected in these reviews.
Some of those advances are in the form of consolidation
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of the existing positive evidence, some are new conclu-
sions, and some are disappointingly negative findings.
One key finding is that relatively few patients who are
referred to specialist services either make it through to
treatment or complete that treatment [9]. This finding




A number of motivational approaches have been trialled
as adjuncts to other therapeutic methods. The recent
evidence from this work is mixed, with motivational
enhancement therapy proving relatively ineffective for
inpatients with eating disorders (leading to little reliable
change in motivation or in eating pathology itself) [10].
There is some evidence of increased motivational benefit
among binge eaters, though there is less consistency
regarding change in their eating pathology [11,12].
Cognitive behavioural therapy
Among bulimic cases, CBT has extended its evidence
base considerably [13]. That development parallels
improvements in this form of therapy [14,15], although
whether CBT is actually applied in broad clinical practice
is questionable [16]. It has been shown that CBT can be
individualised and applied to patients in non-research
settings [17]. The most important finding is an improved
outcome with bulimic cases (and comparable outcomes
with atypical cases – see below) [18]. There is pre-
liminary evidence that relatively complex cases benefit
most from a more complex form of CBT [18] and that
some in-patients can benefit from a CBT-based pro-
gramme [19]. However, CBT remains unproven with
relatively low-weight anorexic patients, where physical
needs and starvation effects predominate.
Dialectical behaviour therapy
Dialectical behaviour therapy (DBT) has previously been
proposed for use with bulimia and binge eating disorder.
This stance has been supported by recent work using a
version of DBT that is only minimally adapted from the
original [20].
Medication
There has been some advance in the field of psycho-
pharmacology for bulimic eating disorders over the past
few years, though these findings need replication and
extension. First, there is some evidence that fluoxetine is
useful for bulimic adolescents [21]. Second, sibutramine
may be effective in the treatment of binge eating disorder
[22]. Finally, topirimate seems to be effective in the short
term for bulimic disorders where there is comorbid
obesity [23].
There is no clear evidence for medication in the
treatment of the core symptoms of anorexia nervosa,
regardless of age [21,24]. There have been some
suggestions that olanzapine might be a useful adjunct
to other treatments for anorexia nervosa (particularly
given its tendency to promote weight gain). However, it
is too early to support this contention, given the differing
outcomes of recent studies, their methodological weak-
nesses, and the lack of clarity about the mechanisms that
might be involved [25-27].
Specific subgroups of eating disordered patients
Atypical cases
As already identified, atypical cases constitute a very
large proportion of the eating disordered population
[5], but there has been almost no evidence on their
treatment (beyond the subgroup of binge eating
disorder patients). This gap has been addressed recently
in adults and adolescents. Such cases can be successfully
treated using similar methods to those employed with
bulimic disorders, with broadly comparable outcomes
[17,18,28].
Younger cases
Family-oriented therapies still have a pre-eminent
position with adolescents with anorexia nervosa [29].
However, there is now good evidence that both family




Recent findings in this domain have been uninspiring.
A recent review has concluded that self-help for bulimia
nervosa and binge eating disorder is beneficial, but only
relative to a waiting list control condition. There is little
evidence that this approach is more helpful than any
active control condition [31].
Electronic delivery
Various researchers have tested electronic methods (for
example, via internet, text messages, and CD-ROM) of
delivering treatments that are effective when delivered
individually. Unfortunately, the results are relatively
weak and uptake is poor, leading to the conclusion that
this is not yet a method of conducting therapy that can
be widely recommended [32,33].
Implications for clinical practice
In brief, recent findings reiterate and extend the role
of CBT as the first line treatment for most adult cases of
eating disorders (provided the CBT is delivered appro-
priately), extending its utility to younger cases and to
atypical cases, and showing its effectiveness in
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non-research settings. However, existing self-help meth-
ods and the use of electronic media for delivery of CBT
are not supported at present. The role of family therapy
for younger cases is also more widely supported. There
are more positive findings regarding the use of DBT and
medication for bulimic disorders, but medication is not
indicated for the core pathology of anorexia nervosa.
Future directions in clinical research in therapies for
the eating disorders
Over the next few years, it will be important to monitor
the following aspects of the treatment literature in the
eating disorders:
1. Continued developments of psychological therapies for
bulimic disorders and atypical eating disorders (for
example, CBT, DBT), to enhance existing outcomes and
to carry these effects further into everyday clinical practice.
2. Treatment outcomes for anorexia nervosa, including
psychological and psychopharmacological approaches
(findings are anticipated from a number of current
trials).
3. The development of psychopharmacological
approaches that relate to the psychobiology of the eating
disorders (including anxiety structures) [34] that have
more extensive periods of follow-up.
4. Psychological therapies that have been proposed to be
valuable but where the evidence base is minimal should
be tested more fully in order to demonstrate whether or
not they meet the criteria for evidence-based practice.
5. The matching of psychological therapies to indivi-
duals, to ensure that individuals are offered the most
effective treatment for their individual problem [18].
6. Working via carers, addressing both their own stress
and making them more able to work as members of the
broader team treating the sufferer [35].
7. The determination of whether treatment effects
generalise across settings (for example, do therapies for
restrictive problems tested in outpatient settings work as
well in day- and in-patient settings?).
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